Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Neuro-Oncology|May 24, 2019
Xenograft-based, platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastomaShuang G Zhao, Menggang Yu, Daniel E Spratt, et al.International Journal of Radiation Oncology, Biology, Physics|May 21, 2020
A Signature That May Be Predictive of Early Versus Late Recurrence After Radiation Treatment for Breast Cancer That May Inform the Biology of Early, Aggressive RecurrencesCorey Speers, S Laura Chang, Andrea Pesch, et al.Molecular Cancer Research : MCR|February 18, 2018
Multigene Profiling of CTCs in mCRPC Identifies a Clinically Relevant Prognostic SignatureUdit Singhal, Yugang Wang, James Henderson, et al.NPJ Genomic Medicine|September 22, 2021
Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT SignaturesNicholas R Rydzewski, Erik Peterson, Joshua M Lang, et al.JAMA Oncology|January 10, 2016
Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate CancerJoseph R Evans, Shuang G Zhao, S Laura Chang, et al.JAMA Oncology|September 23, 2021
Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate CancerRahul Aggarwal, Nicholas R Rydzewski, Li Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2018
Clinical and Genomic Implications of Luminal and Basal Subtypes Across CarcinomasShuang G Zhao, William S Chen, Rajdeep Das, et al.The Lancet. Oncology|October 17, 2016
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysisShuang G Zhao, S Laura Chang, Daniel E Spratt, et al.Journal of the National Cancer Institute|October 16, 2018
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic TargetShuang G Zhao, Jonathan Lehrer, S Laura Chang, et al.Journal of the National Cancer Institute|October 18, 2024
Validation of a breast cancer assay for radiotherapy omission: an individual participant data meta-analysisPer Karlsson, Anthony Fyles, S Laura Chang, et al.Pageof 3